Sign in
4

Changes in Ownership

Hepion Pharmaceuticals, Inc. Filed Acc 0001104659-21-069934

Options or other derivatives

  • Director acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ADAMS THOMAS PHD · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-18 Grant or award : show line 1 in the form Stock Options +200,000 291,050 D
Loading xslF345X03/tm2117144-1_4seq1.xml…